Company Data
Puma Biotechnology Inc
Ticker
PBYI
Current Price
$5.04 1.41%
Market Cap
$253.9M
Price Target
Refer to Report
Volume
377.5K
52wk Range
$2.225 - $6.07
Overview
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.